These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31894418)

  • 1. 6-Hydroxydopamine: a far from simple neurotoxin.
    Varešlija D; Tipton KF; Davey GP; McDonald AG
    J Neural Transm (Vienna); 2020 Feb; 127(2):213-230. PubMed ID: 31894418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of 6-hydroxydopamine neurotoxicity.
    Glinka Y; Gassen M; Youdim MB
    J Neural Transm Suppl; 1997; 50():55-66. PubMed ID: 9120425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.
    Henze C; Earl C; Sautter J; Schmidt N; Themann C; Hartmann A; Oertel WH
    Brain Res; 2005 Aug; 1052(1):97-104. PubMed ID: 16005444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease.
    Soto-Otero R; Méndez-Alvarez E; Hermida-Ameijeiras A; Muñoz-Patiño AM; Labandeira-Garcia JL
    J Neurochem; 2000 Apr; 74(4):1605-12. PubMed ID: 10737618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage.
    Mayo JC; Sainz RM; Antolín I; Rodriguez C
    Brain Res; 1999 Feb; 818(2):221-7. PubMed ID: 10082807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of iron in 6-hydroxydopamine neurotoxicity.
    Double KL; Riederer PF; Gerlach M
    Adv Neurol; 1999; 80():287-96. PubMed ID: 10410733
    [No Abstract]   [Full Text] [Related]  

  • 9. Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties.
    Olatunji OJ; Feng Y; Olatunji OO; Tang J; Ouyang Z; Su Z
    Biomed Pharmacother; 2016 Jul; 81():7-14. PubMed ID: 27261571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin I protects the dopaminergic cell line SH-SY5Y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosis.
    Jaisin Y; Thampithak A; Meesarapee B; Ratanachamnong P; Suksamrarn A; Phivthong-Ngam L; Phumala-Morales N; Chongthammakun S; Govitrapong P; Sanvarinda Y
    Neurosci Lett; 2011 Feb; 489(3):192-6. PubMed ID: 21167259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.
    Lotharius J; Dugan LL; O'Malley KL
    J Neurosci; 1999 Feb; 19(4):1284-93. PubMed ID: 9952406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
    Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
    FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of the thioredoxin and glutaredoxin systems in dopamine-induced cell death.
    Arodin L; Miranda-Vizuete A; Swoboda P; Fernandes AP
    Free Radic Biol Med; 2014 Aug; 73():328-36. PubMed ID: 24863694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of valproic acid on 6-hydroxydopamine-induced neuroinjury.
    Hsu SW; Hsu PC; Chang WS; Yu CC; Wang YC; Yang JS; Tsai FJ; Chen KY; Tsai CW; Bau DT
    Environ Toxicol; 2020 Aug; 35(8):840-848. PubMed ID: 32167238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis.
    Walkinshaw G; Waters CM
    Neuroscience; 1994 Dec; 63(4):975-87. PubMed ID: 7535401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson's disease.
    Lv H; Liu J; Wang L; Zhang H; Yu S; Li Z; Jiang F; Niu Y; Yuan J; Cui X; Wang W
    Cell Biochem Biophys; 2014 Nov; 70(2):1433-8. PubMed ID: 24989681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson's disease.
    Naughton C; Moriarty N; Feehan J; O'Toole D; Dowd E
    Behav Brain Res; 2016 Jan; 296():451-458. PubMed ID: 26393432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.
    Dluzen D
    Brain Res; 1997 Sep; 767(2):340-4. PubMed ID: 9367266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Hydroxydopamine induces mitochondrial ERK activation.
    Kulich SM; Horbinski C; Patel M; Chu CT
    Free Radic Biol Med; 2007 Aug; 43(3):372-83. PubMed ID: 17602953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.